Table 1.
Enriched gRNAs in the MHC IIhigh population.
FC | log10(p value) | Gene | Name | gRNAs |
---|---|---|---|---|
6.04 | 7.313 | March1 | E3 ubiquitin-protein ligase MARCH1 | 2 |
5.82 | 8.362 | Cbfb | Core-binding factor subunit beta | 1 |
3.33 | 8.503 | Ahr | Aryl hydrocarbon receptor | 1 |
3.16 | 5.923 | Ubl3 | Ubiquitin-like protein 3 | 3 |
2.78 | 8.049 | Kdm2b | Lysine-specific demethylase 2B | 1 |
2.71 | 9.817 | Runx3 | Runt-related transcription factor 3 | 1 |
2.65 | 5.512 | Ldb3 | LIM domain-binding protein 3 | 1 |
2.54 | 6.780 | Max | Protein max | 1 |
2.51 | 5.556 | Amn1 | Antagonist of mitotic exit network 1 | 1 |
2.42 | 9.681 | Runx1 | Runt-related transcription factor 1 | 1 |
2.25 | 26.770 | Mxi1 | Max-interacting protein 1 | 1 |
2.19 | 9.306 | Pcgf1 | Polycomb group RING finger protein 1 | 2 |
P values were assessed using a negative binomial generalized linear model with a two-sided likelihood ratio test, with adjustment for multiple testing using the Benjamini–Hochberg false discovery rate (FDR) method. Shown are hits with false discovery rate <0.01 and >2-fold enrichment over the reference library. FC fold change, gRNAs number of gRNAs detected.